DJIA 17,949.59 -85.34 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

Array BioPharma CEO Sees Big Opportunities in the Future

Type 1 Diabetes, Progress With Stem Cells And Other Cell-Based Therapies

The Best Dividend-Paying Healthcare Stocks

These three healthcare stocks could offer the best blend of sales and dividend growth in the sector.

Medivation-Astellas' Xtandi Positive in Prostate Cancer Study - Analyst Blog

Stocks to Cure What Ails on World TB Day - Analyst Blog

Biogen Gains on Positive Alzheimer's Drug Interim Results - Analyst Blog

Why It’s Not Too Late to Buy Isis Pharmaceuticals Stock

Isis Pharmaceuticals has had an enormous run of late. Is this drugmaker still a buy?

This is Why Diabetes Treatment Costs Are Soaring

A new class of diabetes drugs is driving up the cost of diabetes medicine.

Why Pfizer Inc. Isn't Built to Last

Pfizer may be about to break up. Here's what investors need to know.

AstraZeneca, Daiichi Sankyo to Co-Market Movantik in U.S. - Analyst Blog

See More Articles...